
ESCMID Global 2025: Global access issues remain for long-acting HIV injectables
The impact of long-acting injectables (LAIs) for HIV was discussed at the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Vienna, Austria. Historically, managing HIV has required a lifelong commitment to …